Clinical Trial Update: Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating desmopressin for nocturia in patients with obstructive sleep apnea was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia
• Obstructive Sleep Apnea

Drugs mentioned

• Desmopressin (Desmopressin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Nocturia, Obstructive Sleep Apnoea | Phase 3 | Status: TERMINATED